Stock Research for GRFS


Featured Broker: Ally Invest

Get the due diligence for another stock.


GRFS Stock Chart & Research Data

The GRFS chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the GRFS chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


GRFS Due diligence Resources & Stock Charts

The GRFS stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View GRFS Detailed Price Forecast - CNN Money CNN View GRFS Detailed Summary - Google Finance
Yahoo View GRFS Detailed Summary - Yahoo! Finance Zacks View GRFS Stock Research & Analysis -

Stock Analysis

TradeIdeas View GRFS Trends & Analysis - Trade-Ideas Barrons View GRFS Major Holders - Barrons
NASDAQ View GRFS Call Transcripts - NASDAQ Seeking View GRFS Breaking News & Analysis - Seeking Alpha
Spotlight View GRFS Annual Report - OTC Report View GRFS OTC Short Report -
TradeKing View GRFS Fundamentals - TradeKing Charts View GRFS SEC Filings - Bar Chart
WSJ View Historical Prices for GRFS - The WSJ Morningstar View Performance/Total Return for GRFS - Morningstar
MarketWatch View the Analyst Estimates for GRFS - MarketWatch CNBC View the Earnings History for GRFS - CNBC
StockMarketWatch View the GRFS Earnings - StockMarketWatch MacroAxis View GRFS Buy or Sell Recommendations - MacroAxis
Bullish View the GRFS Bullish Patterns - American Bulls Short Pains View GRFS Short Pain Metrics -

Social Media Mentions

StockTwits View GRFS Stock Mentions - StockTwits PennyStocks View GRFS Stock Mentions - PennyStockTweets
Twitter View GRFS Stock Mentions - Twitter Invest Hub View GRFS Investment Forum News - Investor Hub
Yahoo View GRFS Stock Mentions - Yahoo! Message Board Seeking Alpha View GRFS Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for GRFS - Insider Cow View Insider Transactions for GRFS - Insider Cow
CNBC View GRFS Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for GRFS - OTC Markets
Yahoo View Insider Transactions for GRFS - Yahoo! Finance NASDAQ View Institutional Holdings for GRFS - NASDAQ

Stock Charts

FinViz View GRFS Stock Insight & Charts - StockCharts View GRFS Investment Charts -
BarChart View GRFS Stock Overview & Charts - BarChart Trading View View GRFS User Generated Charts - Trading View

Latest Financial News for GRFS

Grifols Expands its NAT Solutions Portfolio with New FDA Approvals for Two Assays
Posted on Tuesday June 19, 2018

- Grifols Procleix Ultrio Elite assay screens for HIV-1, HCV, and HBV and detects HIV-2; the Procleix WNV assay screens for West Nile virus - Both assays are approved to run on the fully automated NAT ...

2 Stable and 2 Speculative Biotech Stocks to Buy
Posted on Friday June 15, 2018

Biotech stocks represent a peculiar conundrum. Successes here could spark revolutionary therapies that could end or at least alleviate human suffering. Thus, creating a list of biotech stocks to buy will always be a tough challenge.

Factors of Influence in 2018, Key Indicators and Opportunity within Eldorado Gold, Lamar Advertising, Bitauto, Magellan Midstream Partners, Deutsche Bank Aktiengesellschaft, and Grifols, S.A. — New Research Emphasizes Economic Growth
Posted on Thursday June 07, 2018

NEW YORK, June 07, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Eldorado ...

Grifols Launches a New Testing Service for Patients Treated with Daratumumab
Posted on Thursday May 31, 2018

BARCELONA, Spain, May 31, 2018 /PRNewswire/ -- Grifols (MCE: GRF, MCE: GRF.P and NASDAQ: GRFS), one of the leading companies in the world in plasma-derived biological medicines and transfusion medicine, today announced it is adding a Daratumumab neutralization testing service to its extensive menu of services offered at Grifols Immunohematology Center laboratory (San Marcos, Texas). This new test facilitates complete antibody screening and identification in pretransfusion testing of patients under this therapy.

Enter a stock symbol to view the stock details.